389 related articles for article (PubMed ID: 35589257)
21. Restoration of dysbiotic human gut microbiome for homeostasis.
Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
[TBL] [Abstract][Full Text] [Related]
22. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory Bowel Diseases and Gut Microbiota.
Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota and acute graft-versus-host disease.
Yoshioka K; Kakihana K; Doki N; Ohashi K
Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota and its metabolites in depression: from pathogenesis to treatment.
Liu L; Wang H; Chen X; Zhang Y; Zhang H; Xie P
EBioMedicine; 2023 Apr; 90():104527. PubMed ID: 36963238
[TBL] [Abstract][Full Text] [Related]
26. Intestinal microbiota in liver disease.
Haque TR; Barritt AS
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
[TBL] [Abstract][Full Text] [Related]
27. Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosis.
Woodhouse C; Singanayagam A; Patel VC
Clin Med (Lond); 2020 Sep; 20(5):493-500. PubMed ID: 32934044
[TBL] [Abstract][Full Text] [Related]
28. Rebuilding the Gut Microbiota Ecosystem.
Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270
[TBL] [Abstract][Full Text] [Related]
29. Gut microbiota and sepsis: from pathogenesis to novel treatments.
Kullberg RFJ; Wiersinga WJ; Haak BW
Curr Opin Gastroenterol; 2021 Nov; 37(6):578-585. PubMed ID: 34419965
[TBL] [Abstract][Full Text] [Related]
30. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health.
Parker A; Fonseca S; Carding SR
Gut Microbes; 2020; 11(2):135-157. PubMed ID: 31368397
[TBL] [Abstract][Full Text] [Related]
31. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis.
Bajaj JS; Khoruts A
J Hepatol; 2020 May; 72(5):1003-1027. PubMed ID: 32004593
[TBL] [Abstract][Full Text] [Related]
32. Alcohol, liver disease and the gut microbiota.
Bajaj JS
Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiome and non-alcoholic fatty liver disease.
Purohit A; Alam MJ; Kandiyal B; Shalimar ; Das B; Banerjee SK
Prog Mol Biol Transl Sci; 2022; 191(1):187-206. PubMed ID: 36270678
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota in autoimmunity: potential for clinical applications.
Kim D; Yoo SA; Kim WU
Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
[TBL] [Abstract][Full Text] [Related]
35. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
Lee P; Yacyshyn BR; Yacyshyn MB
Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
[TBL] [Abstract][Full Text] [Related]
36. Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases.
Liu J; Yang D; Wang X; Asare PT; Zhang Q; Na L; Shao L
Front Cell Infect Microbiol; 2022; 12():774335. PubMed ID: 35444959
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiome-targeted therapies for Alzheimer's disease.
Zhang T; Gao G; Kwok LY; Sun Z
Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
[TBL] [Abstract][Full Text] [Related]
38. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
Wing AC; Kremenchutzky M
Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
[TBL] [Abstract][Full Text] [Related]
39. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value.
Li ZJ; Gou HZ; Zhang YL; Song XJ; Zhang L
World J Gastroenterol; 2022 Nov; 28(44):6213-6229. PubMed ID: 36504550
[TBL] [Abstract][Full Text] [Related]
40. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong M; Han DH; Hong J; Kim DJ; Suk KT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
